News Search Results
Nov 11, 2025, 09:00 ET Strategic Partnership Between Sanyou Bio and Yugong Bio to Accelerate Expansion in High-End Synthetic Enzyme Market
accelerating drug discovery. Yugong Bio is a national high-tech enterprise focusing on upstream molecular enzyme reagents for synthetic biology and their application solutions. The company possesses strong capabilities in enzyme molecular engineering and cell-free protein synthesis. Its
More news about: Sanyou Bio
Nov 10, 2025, 10:50 ET ERS Genomics and Dyadic Applied BioSolutions Sign CRISPR/Cas9 License Agreement
cell lines and animal models for drug screening, bioproduction of antibodies and therapeutic proteins, animal and agricultural biotechnology, synthetic biology, including production of enzymes, food ingredients, and bio-based chemicals. Current ERS licensees include GSK, Merck,
More news about: ERS Genomics
Nov 10, 2025, 08:45 ET Enzymit Achieves World's First Scaled Cell-Free Production of Hyaluronic Acid
Nov. 10, 2025 /PRNewswire/ -- Enzymit, a synthetic biology company pioneering cell-free biomanufacturing, in partnership with Cosun,
More news about: Enzymit
Nov 06, 2025, 16:05 ET Ginkgo Bioworks Reports Third Quarter 2025 Financial Results
business opportunities, including with respect to our solutions and tools offerings, (iv) the risk of downturns in demand for products using synthetic biology, (v) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (vi) changes to the biosecurity industry,
More news about: Ginkgo Bioworks
Nov 03, 2025, 08:00 ET Ginkgo Bioworks Awarded Project Agreement through BARDA's BioMaP-Consortium
This BARDA-supported initiative builds on Ginkgo Bioworks' track record in partnering with the U.S. government to provide ongoing leadership in synthetic biology, biomanufacturing innovation, and national biosecurity preparedness. This project has been funded in whole or in part with
More news about: Ginkgo Bioworks
Nov 03, 2025, 07:10 ET Partillion Launches Developer Kits, Powering Customer-Led Innovation on Nanovials
single-cell or multicell assays and select capture antibodies suited for applications in immunology, antibody discovery, cell therapy development, synthetic biology, and aging research. Partillion is also providing detailed documentation to help teams design and optimize their own assays.
More news about: Partillion Bioscience
Oct 31, 2025, 08:00 ET Ginkgo Bioworks and Bayer Extend Multi-Year Strategic Partnership to Accelerate Next Generation Biological Solutions for Agriculture
business opportunities, including with respect to our solutions and tools offerings, (iv) the risk of downturns in demand for products using synthetic biology, (v) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (vi) changes to the biosecurity industry,
More news about: Ginkgo Bioworks
Oct 31, 2025, 06:30 ET Agriculture Biotechnology Market worth $144.25 billion by 2030- Exclusive Report by MarketsandMarkets™
chemical dependence and boost resilience against climate-related stresses. Furthermore, increasing investments in AI-integrated biotechnology, synthetic biology, and sustainable input development are expanding market potential. Browse in-depth
More news about: MarketsandMarkets
Oct 28, 2025, 10:15 ET Cell-free Protein Synthesis Market worth $308.9 million by 2030 with 7.3% CAGR | MarketsandMarkets™
cell-free systems for complex protein production. The market also offers promising opportunities in commercial validation, vaccine development, synthetic biology, biosensor creation, and expanding into personalized medicine and therapeutic proteins. Adoption among research labs and pharmaceutical firms
More news about: MarketsandMarkets
Oct 24, 2025, 08:16 ET BiomEdit Awarded Nearly $2 Million from Bezos Earth Fund to Advance AI Model for Methane-Reduction Strategies in Cattle
BiomEdit BiomEdit is an animal health microbial biotechnology company leveraging the power of the microbiome and synthetic biology to develop next-generation solutions for livestock and pet health. Founded in 2022, BiomEdit is backed by leading investors Anterra Capital, Viking
More news about: BiomEdit
Oct 23, 2025, 08:00 ET Ginkgo Bioworks in Partnership with STRM.BIO and University of British Columbia in Project to Develop In Vivo CAR Therapies Under ARPA-H's EMBODY Program
business opportunities, including with respect to our solutions and tools offerings, (iv) the risk of downturns in demand for products using synthetic biology, (v) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (vi) changes to the biosecurity industry,
More news about: Ginkgo Bioworks
Oct 22, 2025, 11:16 ET UpTerra brings on new Chief Science Officer with Shiv Tiwari, Ph.D., former GreenVenus CEO and CTO
R&D. He's brought his scientific depth and leadership presence to companies including venture capital and private equity firm Third Security, synthetic biology business Intrexon, Mendel Biotechnology, and Corteva (DuPont Pioneer). Dr. Tiwari has lectured and taught at the University
More news about: UpTerra
Oct 16, 2025, 14:40 ET Proya Cosmetics Shares Its Vision for the Future of Beauty at Cosmetic 360, Highlighting Scientific Advances and Brand Innovations
use. The company collaborates with academic partners, hospitals, leading research institutes and synthetic biology companies to remain at the forefront of technology, particularly in the field of artificial intelligence. As an example, Proya Cosmetics is partnering
More news about: Proya Cosmetics
Oct 16, 2025, 09:33 ET Meet Caravel: Pioneering a New Era of Biotechnology with the First Unified Platform for Protein Discovery and Delivery
Caravel Bio, the first joint platform for protein discovery and delivery that enables new applications of synthetic biology, today announces its selection for a $7.8 million award from the U.S. National Science Foundation Directorate for Technology, Innovation and Partnerships
More news about: Caravel Bio
Oct 13, 2025, 15:03 ET Algae Products Market to Reach USD 9.7Billion by 2032, Growing At An 7% CAGR - Credence Research
Development of Novel Algae Strains and Bioengineering Applications Advances in genetic research, synthetic biology, and strain optimization technologies are enabling the development of novel algae varieties with enhanced productivity, targeted nutritional profiles,
More news about: Credence Research Inc.
Oct 09, 2025, 06:04 ET Beijing Review: Rivers, Rice and Revolution
years, Dafeng Port has explored a "green electricity + hydrogen" development model, fostering industries such as green hydrogen and marine and synthetic biology, and supporting the transition of traditional sectors like steel, paper and chemicals. Muhammad Asghar, chief reporter
More news about: Beijing Review
Sep 30, 2025, 11:45 ET Made Scientific and Syenex Forge Technology Partnership to Transform T Cell Therapy Manufacturing
2025 /PRNewswire/ -- Made Scientific, a leading cell therapy contract development and manufacturing organization (CDMO) and Syenex, a synthetic biology company specializing in best-in-class targeted delivery technologies, today announced a technology partnership to advance the scalability and
More news about: Made Scientific, Inc.
Sep 30, 2025, 09:00 ET K18 and Future Society Launch First-Ever Biotech Beauty Collaboration With Limited-Edition Floating Forest Hair Mask
repair service that protects, strengthens, and preserves hair health through even extreme salon services. As the leader in synthetic biology for beauty, K18 sets itself apart by addressing hair health from the inside out, rather than relying on surface-level solutions. With over 20
More news about: K18 Biomimetic Hairscience
Sep 25, 2025, 09:37 ET The FDA Granted Orphan Drug Designation to Biostar Pharma's Utidelone for the Treatment of Pancreatic Cancer
Biostar Pharma, Inc., the US wholly-owned subsidiary of Beijing Biostar Biopharmaceutical Co., Ltd. ("Biostar," stock code: 2563.HK) which is a synthetic biology driven biopharma company focusing on the discovery, development and commercialization of innovative oncology drugs, is pleased to announce that
More news about: Biostar Pharma, Inc.
Sep 24, 2025, 09:00 ET Hood College Receives NSF Grant for Biotechnology Training Program
Foundation's Experiential Learning for Emerging and Novel Technologies (ExLENT) program to launch the Innovative, Immersive Training Program in Synthetic Biology and Biomanufacturing.
More news about: Hood College
Sep 18, 2025, 09:20 ET AIChE Awards Its 2025 Langer Prize to Mark Blenner of the University of Delaware
efficiently process mixed, uncleaned plastic waste and be deployed in decentralized systems, making them attractive for plastic upcycling. Synthetic biology can enhance these solutions for industrial applications. Blenner's blue-sky idea was selected from a global candidate pool with
More news about: American Institute Of Chemical Engineers
Sep 17, 2025, 12:00 ET Terra Oleo Emerges from Stealth with US$3.1M in Funding and Breakthrough Energy Fellow Selection to Reinvent Fats and Oils
precision fermentation to transform agro-industrial waste into sustainable palm oil ingredients and cocoa butter alternatives. Backed by deep synthetic biology and microbial engineering expertise, the platform delivers tailored lipid profiles for high-value palm and cocoa applications, while eliminating
More news about: Terra Oleo
Sep 15, 2025, 08:00 ET Biostar Pharma Successively Achieved First Patient Dosing for Two Phase II/III Multiregional Clinical Trials of Utidelone Capsule (UTD2)
/PRNewswire/ -- Biostar Pharma, Inc., the US subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. ("Biostar", Stock Code: 2563.HK) which is a synthetic biology driven biopharma company focusing on the discovery, development and commercialization of innovative oncology drugs, is pleased to announce that
More news about: Biostar Pharma, Inc.
Sep 12, 2025, 10:01 ET Ligase Enzymes Market worth US$0.36 billion by 2030 with 6.8% CAGR | MarketsandMarkets™
growing due to the rising demand for molecular diagnostics, the increasing adoption of next-generation sequencing (NGS), expanding applications in synthetic biology, and continuous advancements in enzyme engineering. The growing use of ligases in molecular diagnostics, particularly in cancer genomics, infectious
More news about: MarketsandMarkets
Sep 08, 2025, 12:07 ET Cerillo to launch Rayo: Next-Gen Multiwavelength Microplate Reader at Analytica USA 2025
microplate readers, the Duet® co-culture system, Labrador® software, and Canopy® wireless accessories, Cerillo empowers labs across microbiome, synthetic biology, environmental, and pharmaceutical research to conduct high-quality science anywhere, whether in the field or in restricted spaces. Rayo
More news about: Cerillo